Aude Charbonnier Selected Research

Aude Charbonnier Research Topics

Disease

17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 07/2008
13	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 04/2007
7	Neoplasms (Cancer) 12/2021 - 07/2002
5	Leukemia 01/2023 - 11/2012
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 07/2012
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 07/2002
3	Philadelphia Chromosome 01/2024 - 03/2010
2	Infections 01/2022 - 12/2021
2	Pleural Effusion (Pleural Effusions) 01/2021 - 07/2008
2	Residual Neoplasm 01/2017 - 02/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2004 - 09/2003
1	Hepatitis 12/2023
1	Hemorrhage 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2022
1	Heart Failure 01/2020
1	Hypertension (High Blood Pressure) 11/2018
1	Headache (Headaches) 04/2018
1	Fatigue 04/2018
1	Asthenia 04/2018
1	Hematologic Neoplasms (Hematological Malignancy) 04/2018
1	Pruritus (Itching) 04/2018
1	Weight Gain 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2016
1	Bronchiolitis Obliterans Syndrome 03/2014
1	Pathologic Complete Response 11/2012
1	Breast Neoplasms (Breast Cancer) 03/2012
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2011
1	Iron Overload 12/2010
1	Thrombocytopenia (Thrombopenia) 07/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2003
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2002
1	Plasma Cell Leukemia 07/2002

Drug/Important Bio-Agent (IBA)

12	Imatinib Mesylate (Gleevec)FDA Link 01/2024 - 07/2008
10	Tyrosine Kinase InhibitorsIBA 01/2024 - 02/2014
6	Dasatinib (BMS 354825)FDA Link 01/2024 - 07/2008
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 03/2011
4	nilotinib FDA Link 01/2024 - 01/2011
4	Azacitidine (5 Azacytidine)FDA Link 04/2022 - 07/2013
2	bosutinibIBA 01/2024 - 12/2023
2	Oncogene Proteins (Oncogene Protein)IBA 12/2023 - 02/2016
2	AnthracyclinesIBA 01/2020 - 11/2012
2	KIR ReceptorsIBA 04/2018 - 11/2012
2	epratuzumabIBA 01/2017 - 04/2015
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	venetoclaxIBA 04/2022
1	eculizumab FDA Link 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	pyrimidineIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	fludarabineIBA 01/2019
1	Busulfan (Busulfex)FDA Link 01/2019
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2019
1	ponatinibIBA 11/2018
1	CoagulantsIBA 11/2018
1	lirilumabIBA 04/2018
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Natural Killer Cell ReceptorsIBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	CytokinesIBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	abexinostatIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2015
1	Vincristine (Oncovin)FDA LinkGeneric 04/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2015
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2014
1	Vorinostat FDA Link 01/2014
1	Lenalidomide (CC 5013)FDA Link 07/2013
1	IPH-2101IBA 11/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2012
1	Bortezomib (Velcade)FDA Link 07/2012
1	Trastuzumab (Herceptin)FDA Link 03/2012
1	Gemtuzumab (Mylotarg)FDA Link 03/2011
1	IronIBA 12/2010
1	InterferonsIBA 11/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2004
1	Rituximab (Mabthera)FDA Link 09/2003
1	VaccinesIBA 07/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 04/2024 - 09/2003
5	Therapeutics 01/2022 - 02/2014
3	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2014
3	Stem Cell Transplantation 01/2020 - 11/2010
2	Aftercare (After-Treatment) 12/2023 - 01/2018
2	Salvage Therapy 01/2023 - 04/2022
2	Induction Chemotherapy 11/2012 - 04/2007
1	Contraindications 01/2020
1	Haploidentical Transplantation 01/2019
1	Transplantation 10/2014
1	Chelation Therapy (Therapy, Chelation) 12/2010
1	Radiotherapy 02/2004
1	Immunotherapy 07/2002